Literature DB >> 29703844

A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes.

Natalie R van Zuydam1,2, Emma Ahlqvist3, Niina Sandholm4,5,6, Harshal Deshmukh7, N William Rayner8,2,9, Moustafa Abdalla8,2,10, Claes Ladenvall3, Daniel Ziemek11, Eric Fauman12, Neil R Robertson8,2, Paul M McKeigue13, Erkka Valo4,5,6, Carol Forsblom4,5,6, Valma Harjutsalo4,5,6,14, Annalisa Perna15, Erica Rurali15, M Loredana Marcovecchio16, Robert P Igo17, Rany M Salem18, Norberto Perico15, Maria Lajer19, Annemari Käräjämäki20,21, Minako Imamura22,23,24, Michiaki Kubo24, Atsushi Takahashi25,26, Xueling Sim27, Jianjun Liu27,28,29, Rob M van Dam27, Guozhi Jiang30, Claudia H T Tam30, Andrea O Y Luk30,31,32, Heung Man Lee30,31,32,33, Cadmon K P Lim30, Cheuk Chun Szeto30, Wing Yee So30, Juliana C N Chan30,31,32, Su Fen Ang34, Rajkumar Dorajoo28, Ling Wang28, Tan Si Hua Clara34, Amy-Jayne McKnight35, Seamus Duffy35, Marcus G Pezzolesi36, Michel Marre37, Beata Gyorgy37, Samy Hadjadj38,39,40, Linda T Hiraki41, Tarunveer S Ahluwalia19,42, Peter Almgren43, Christina-Alexandra Schulz43, Marju Orho-Melander43, Allan Linneberg44,45,46, Cramer Christensen47, Daniel R Witte48,49, Niels Grarup42, Ivan Brandslund50,51, Olle Melander52, Andrew D Paterson41, David Tregouet37, Alexander P Maxwell35, Su Chi Lim53,54,55, Ronald C W Ma30,31,32,33, E Shyong Tai27,54,56, Shiro Maeda22,23,24, Valeriya Lyssenko3,57, Tiinamaija Tuomi4,6,58,59, Andrzej S Krolewski60, Stephen S Rich61, Joel N Hirschhorn62,63,64, Jose C Florez63,65,66, David Dunger16,67, Oluf Pedersen42, Torben Hansen42,68, Peter Rossing19,42, Giuseppe Remuzzi15,69,70, Mary Julia Brosnan71, Colin N A Palmer72, Per-Henrik Groop4,5,6,73, Helen M Colhoun74, Leif C Groop3,59, Mark I McCarthy8,2,75.   

Abstract

Identification of sequence variants robustly associated with predisposition to diabetic kidney disease (DKD) has the potential to provide insights into the pathophysiological mechanisms responsible. We conducted a genome-wide association study (GWAS) of DKD in type 2 diabetes (T2D) using eight complementary dichotomous and quantitative DKD phenotypes: the principal dichotomous analysis involved 5,717 T2D subjects, 3,345 with DKD. Promising association signals were evaluated in up to 26,827 subjects with T2D (12,710 with DKD). A combined T1D+T2D GWAS was performed using complementary data available for subjects with T1D, which, with replication samples, involved up to 40,340 subjects with diabetes (18,582 with DKD). Analysis of specific DKD phenotypes identified a novel signal near GABRR1 (rs9942471, P = 4.5 × 10-8) associated with microalbuminuria in European T2D case subjects. However, no replication of this signal was observed in Asian subjects with T2D or in the equivalent T1D analysis. There was only limited support, in this substantially enlarged analysis, for association at previously reported DKD signals, except for those at UMOD and PRKAG2, both associated with estimated glomerular filtration rate. We conclude that, despite challenges in addressing phenotypic heterogeneity, access to increased sample sizes will continue to provide more robust inference regarding risk variant discovery for DKD.
© 2018 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2018        PMID: 29703844      PMCID: PMC6014557          DOI: 10.2337/db17-0914

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  48 in total

Review 1.  Nephropathy of type 1 and type 2 diabetes: diverse pathophysiology, same treatment?

Authors:  P Ruggenenti; G Remuzzi
Journal:  Nephrol Dial Transplant       Date:  2000-12       Impact factor: 5.992

2.  Targeted genome-wide investigation identifies novel SNPs associated with diabetic nephropathy.

Authors:  Amy Jayne McKnight; Diane Currie; Chris C Patterson; Alexander P Maxwell; Damian G Fogarty
Journal:  Hugo J       Date:  2010-02-24

Review 3.  Mechanisms of diabetic complications.

Authors:  Josephine M Forbes; Mark E Cooper
Journal:  Physiol Rev       Date:  2013-01       Impact factor: 37.312

4.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy.

Authors:  E R Seaquist; F C Goetz; S Rich; J Barbosa
Journal:  N Engl J Med       Date:  1989-05-04       Impact factor: 91.245

Review 5.  Obesity and diabetic kidney disease.

Authors:  Christine Maric-Bilkan
Journal:  Med Clin North Am       Date:  2012-11-27       Impact factor: 5.456

6.  Validated SNPs for eGFR and their associations with albuminuria.

Authors:  Jaclyn W Ellis; Ming-Huei Chen; Meredith C Foster; Ching-Ti Liu; Martin G Larson; Ian de Boer; Anna Köttgen; Afshin Parsa; Murielle Bochud; Carsten A Böger; Linda Kao; Caroline S Fox; Conall M O'Seaghdha
Journal:  Hum Mol Genet       Date:  2012-04-05       Impact factor: 6.150

7.  Familial factors determine the development of diabetic nephropathy in patients with IDDM.

Authors:  M Quinn; M C Angelico; J H Warram; A S Krolewski
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

8.  Obesity and kidney disease in type 1 and 2 diabetes: an analysis of the National Diabetes Audit.

Authors:  C J Hill; C R Cardwell; A P Maxwell; R J Young; B Matthews; D J O'Donoghue; D G Fogarty
Journal:  QJM       Date:  2013-05-20

9.  Genetic associations in diabetic nephropathy: a meta-analysis.

Authors:  A L Mooyaart; E J J Valk; L A van Es; J A Bruijn; E de Heer; B I Freedman; O M Dekkers; H J Baelde
Journal:  Diabetologia       Date:  2010-12-03       Impact factor: 10.122

10.  Newly identified loci that influence lipid concentrations and risk of coronary artery disease.

Authors:  Cristen J Willer; Serena Sanna; Anne U Jackson; Angelo Scuteri; Lori L Bonnycastle; Robert Clarke; Simon C Heath; Nicholas J Timpson; Samer S Najjar; Heather M Stringham; James Strait; William L Duren; Andrea Maschio; Fabio Busonero; Antonella Mulas; Giuseppe Albai; Amy J Swift; Mario A Morken; Narisu Narisu; Derrick Bennett; Sarah Parish; Haiqing Shen; Pilar Galan; Pierre Meneton; Serge Hercberg; Diana Zelenika; Wei-Min Chen; Yun Li; Laura J Scott; Paul A Scheet; Jouko Sundvall; Richard M Watanabe; Ramaiah Nagaraja; Shah Ebrahim; Debbie A Lawlor; Yoav Ben-Shlomo; George Davey-Smith; Alan R Shuldiner; Rory Collins; Richard N Bergman; Manuela Uda; Jaakko Tuomilehto; Antonio Cao; Francis S Collins; Edward Lakatta; G Mark Lathrop; Michael Boehnke; David Schlessinger; Karen L Mohlke; Gonçalo R Abecasis
Journal:  Nat Genet       Date:  2008-01-13       Impact factor: 38.330

View more
  49 in total

Review 1.  Epigenetics and epigenomics in diabetic kidney disease and metabolic memory.

Authors:  Mitsuo Kato; Rama Natarajan
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 28.314

2.  The Familiality of Rapid Renal Decline in Diabetes.

Authors:  Scott G Frodsham; Zhe Yu; Ann M Lyons; Adhish Agarwal; Melissa H Pezzolesi; Li Dong; Titte R Srinivas; Jian Ying; Tom Greene; Kalani L Raphael; Ken R Smith; Marcus G Pezzolesi
Journal:  Diabetes       Date:  2018-11-13       Impact factor: 9.461

Review 3.  Circadian Clock Genes in Diabetic Kidney Disease (DKD).

Authors:  Olanrewaju A Olaoye; Sarah H Masten; Rajesh Mohandas; Michelle L Gumz
Journal:  Curr Diab Rep       Date:  2019-06-06       Impact factor: 4.810

Review 4.  Does diabetes prevention translate into reduced long-term vascular complications of diabetes?

Authors:  David M Nathan; Peter H Bennett; Jill P Crandall; Sharon L Edelstein; Ronald B Goldberg; Steven E Kahn; William C Knowler; Kieren J Mather; Sunder Mudaliar; Trevor J Orchard; Marinella Temprosa; Neil H White
Journal:  Diabetologia       Date:  2019-07-04       Impact factor: 10.122

Review 5.  The tubular hypothesis of nephron filtration and diabetic kidney disease.

Authors:  Volker Vallon; Scott C Thomson
Journal:  Nat Rev Nephrol       Date:  2020-03-09       Impact factor: 28.314

Review 6.  Rare genetic causes of complex kidney and urological diseases.

Authors:  Emily E Groopman; Gundula Povysil; David B Goldstein; Ali G Gharavi
Journal:  Nat Rev Nephrol       Date:  2020-08-17       Impact factor: 28.314

7.  A Mendelian Randomization Study Provides Evidence That Adiposity and Dyslipidemia Lead to Lower Urinary Albumin-to-Creatinine Ratio, a Marker of Microvascular Function.

Authors:  Francesco Casanova; Andrew R Wood; Hanieh Yaghootkar; Robert N Beaumont; Samuel E Jones; Kim M Gooding; Kunihiko Aizawa; W David Strain; Andrew T Hattersley; Faisel Khan; Angela C Shore; Timothy M Frayling; Jessica Tyrrell
Journal:  Diabetes       Date:  2020-01-08       Impact factor: 9.461

8.  A genome-wide association study implicates multiple mechanisms influencing raised urinary albumin-creatinine ratio.

Authors:  Francesco Casanova; Jessica Tyrrell; Robin N Beaumont; Yingjie Ji; Samuel E Jones; Andrew T Hattersley; Michael N Weedon; Anna Murray; Angela C Shore; Timothy M Frayling; Andrew R Wood
Journal:  Hum Mol Genet       Date:  2019-12-15       Impact factor: 6.150

Review 9.  The Use of Genomics to Drive Kidney Disease Drug Discovery and Development.

Authors:  Dermot F Reilly; Matthew D Breyer
Journal:  Clin J Am Soc Nephrol       Date:  2020-03-19       Impact factor: 8.237

Review 10.  Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors.

Authors:  Annalisa Giandalia; Alfio Edoardo Giuffrida; Guido Gembillo; Domenico Cucinotta; Giovanni Squadrito; Domenico Santoro; Giuseppina T Russo
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.